tirzepatide study after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial Lilly and Company's SURMOUNT-1 study

These combined factors complicate the assessment of risks and benefits in the use of current anti-amyloid therapies

Innovent presents the results of the first phase 3 study of mazdutide for weight management at the ADAs 84th scientific sessions [Internet]

Choosing between semaglutide and tirzepatide requires more than trial averages

With consistent use, expect appetite control, improved mood and metabolic regularity by week 4 backed by science

About retatrutide Retatrutide is an investigational once-weekly triple hormone receptor agonist

Overexpression of a novel Arabidopsis gene related to putative zinc-transporter genes from animals can lead to enhanced zinc resistance and accumulation